Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0026850 (muscular dystrophy)
 5,870 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

There are many neuromuscular diseases associated with cardiomyopathy. Cardiac involvement with progressive muscular dystrophy (Duchenne and Becker type) and some type of limb-girdle muscular dystrophy were characterized by impaired left ventricular systolic function, such as dilated cardiomyopathy like status. In Friedreich ataxia various types of left ventricular hypertrophy were reported. While in myotonic dystrophy and Emery-Dreifuss muscular dystrophy, conduction disturbance and tachyarrhythmia are common types of cardiac manifestation. The severity of cardiac involvement in these diseases is not necessarily concordant with that of skeletal muscle. Recently the genes of these diseases were identified by linkage analysis. We review cardiac abnormalities of these diseases, especially relationship between severity of cardiac disorder and gene abnormalities.
 ...
PMID:[Secondary cardiomyopathy accompanied by neuromuscular disorders]. 1088 12

There are now 21 agents or classes of therapeutic agents in the Friedreich ataxia research pipeline (http://www.curefa.org/pipeline.html) that have been developed in the 15 years since the discovery of the frataxin gene, with the ongoing characterization of its mutations and the resulting molecular pathology. Twenty-four studies are currently posted on ClinicalTrials.gov. Twenty-seven works discussing the results of clinical trials in Friedreich ataxia have been published. In 2010, 42 public (National Institutes of Health) and private (Friedreich Ataxia Research Alliance, Muscular Dystrophy Association, and National Ataxia Foundation) grants were funded for translational and clinical research in Friedreich ataxia. Millions of dollars from public, private, and industry-based initiatives have been dedicated to research in Friedreich ataxia therapeutics. Despite this vigorous international effort, there is as yet no proven disease-modifying therapy for Friedreich ataxia.
 ...
PMID:A review of Friedreich ataxia clinical trial results. 2292 92